Showing results (821-830 of 5,501) with videos related to

Sort By:
Pageof 551
Inflammatory Bowel Diseases|October 12, 2011
Expression of heparan sulfate proteoglycans in murine models of experimental colitisA M Patterson, M I Delday, T H van Kuppevelt, et al.
Inflammatory Bowel Diseases|October 12, 2011
Systematic assessment of factors influencing preferences of Crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL)Stephan R Vavricka, Nicoletta Bentele, Michael Scharl, et al.
Inflammatory Bowel Diseases|October 12, 2011
Human gut-specific homeostatic dendritic cells are generated from blood precursors by the gut microenvironmentElizabeth R Mann, David Bernardo, Hafid Omar Al-Hassi, et al.
Inflammatory Bowel Diseases|March 16, 2012
Exclusive antagonism of the α4 β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primatesEric R Fedyk, Tim Wyant, Li-Li Yang, et al.
Inflammatory Bowel Diseases|February 24, 2012
Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factorsJ R Goodhand, M Wahed, J E Mawdsley, et al.
Inflammatory Bowel Diseases|February 24, 2012
Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims dataDavid T Rubin, Ozgecan Uluscu, Robert Sederman
Inflammatory Bowel Diseases|March 1, 2012
When independent healthcare behaviors develop in adolescents with inflammatory bowel diseaseJulia van Groningen, Sonja Ziniel, Janis Arnold, et al.
Inflammatory Bowel Diseases|April 13, 2011
Aberrant response to commensal Bacteroides thetaiotaomicron in Crohn's disease: an ex vivo human organ culture studyL A Edwards, M Lucas, E A Edwards, et al.
Inflammatory Bowel Diseases|April 13, 2011
Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studiesWalter Reinisch, William J Sandborn, Paul Rutgeerts, et al.
Inflammatory Bowel Diseases|February 26, 2011
Clinical course of Crohn's disease following treatment of lymphomaMarwa El Mourabet, Jana G Hashash, Nicholas H Sun, et al.
Pageof 551